Our clinical experiences of 6 gastroenteropancreatic neuroendocrine tumor (GEP NETs) patients with recurrent liver metastases

被引：0
|
作者：
Nakamura, Shoko [1 ]
Tomisato, Kota [1 ]
Teramoto, Akira [1 ]
Kondo, Akiyuki [1 ]
Matsukawa, Shinobu [1 ]
Yabutani, Akira [1 ]
Iraha, Atsushi [1 ]
Kobashikawa, Kasen [1 ]
Nakamura, Masamoto [1 ]
Nakayoshi, Tomokuni [1 ]
Uchima, Nobufumi [1 ]
Kinjo, Fukunori [1 ]
机构：
[1] Urasoe Gen Hosp, Urasoe City, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2014年 / 29卷
关键词：
neuroendocrine tumor; liver metastases;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-623
引用
收藏
页码：258 / 258
页数：1
相关论文
共 50 条
  • [1] mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
    Zanini, Sara
    Renzi, Serena
    Giovinazzo, Francesco
    Bermano, Giovanna
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [2] The Clinical Impact of Serum Chromogranin-A in Patients With Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Wu, S.
    Reta-Impey, P.
    Manivannan, N.
    Fu, P.
    Cao, S.
    Asa, S.
    Tirumani, S. H.
    Davidson, J.
    Kardan, A.
    Avril, N.
    Wojtylak, P.
    Bajor, D.
    Lee, R.
    Selfridge, E.
    Saltzman, J.
    Ammori, J.
    Hardacre, J.
    Winter, J.
    Mohamed, A.
    PANCREAS, 2021, 50 (03) : 450 - 450
  • [3] SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
    Garcia-Carbonero, Rocio
    Salazar, Ramon
    Sevilla, Isabel
    Isla, Dolores
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (08): : 545 - 551
  • [4] SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (GEP NETS)
    Rocío García-Carbonero
    Ramón Salazar
    Isabel Sevilla
    Dolores Isla
    Clinical and Translational Oncology, 2011, 13 : 545 - 551
  • [5] Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Our Experience in a Multidisciplinary Team in a University Hospital
    Cabezas-Agricola, J. M.
    Baron-Duarte, F.
    Fernandez-Rodriguez, E.
    Varo, E.
    Cameselle-Teijeiro, J. M.
    Iglesias, J.
    Argibay, S.
    Villalba, C.
    Fernandez-Castroagudin, J.
    Otero-Anton, E.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 22 - 23
  • [6] Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases
    Tierney, John F.
    Poirier, Jennifer
    Chivukula, Sitaram
    Pappas, Sam G.
    Hertl, Martin
    Schadde, Erik
    Keutgen, Xavier
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2019, 2019
  • [7] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Inbal Uri
    Simona Grozinsky-Glasberg
    Clinical Diabetes and Endocrinology, 4 (1):
  • [8] Somatostatin receptor scintigraphy (SRS) in the detection of liver metastases from gastroenteropancreatic neuroendocrine tumours (GEP).
    Spanu, A
    Schillaci, O
    Falchi, A
    Marongiu, P
    Pisu, N
    Madeddu, G
    Solinas, ME
    Solinas, P
    Scopinaro, F
    Madeddu, G
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 299P - 299P
  • [9] Clinical Value of MRI DWI and (Gd-EOB)-DTPA to Assess Liver Involvement in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Cwikla, J.
    Sankowski, A.
    Nowicki, M.
    Lewczuk, A.
    Nasierowska-Guttmejer, A.
    Sekelcka, N.
    Walecki, J.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 24 - 25
  • [10] IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Berkovic, Maja Cigrovski
    Jokic, Mladen
    Marout, Jasminka
    Radosevic, Senka
    Zjacic-Rotkvic, Vanja
    Kapitanovic, Sanja
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2007, 83 (03) : 474 - 479
12345